The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1343
ISSUE 1343
July 26, 2010
Issue 1343
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Pitavastatin (Livalo) - The Seventh Statin
July 26, 2010 (Issue: 1343)
The FDA has approved the marketing of pitavastatin (Livalo – Kowa), an HMG-CoA reductase inhibitor
(“statin”), for treatment of primary hyperlipidemia or mixed dyslipidemia. It has been available in Japan
since 2003. All of the statins now...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.